XML 11 R3.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Comprehensive Income - AUD ($)
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Revenue      
License revenue $ 0 $ 0 $ 0
Other income      
Research material sales 59,709 119,089 191,721
Grant income 4,974,823 3,722,788 3,314,001
Net gain on foreign exchange 0 113,458 623,511
Fair value gain on financial assets 9,242 0 0
Net gain on fair value movement of warrants 0 0 131,896
Interest income 5,287,209 3,882,757 938,999
Miscellaneous 390 533 0
Total revenue and other income 10,331,373 7,838,625 5,200,128
Expenses      
Research & development and intellectual property expenses (61,410,533) (41,546,724) (36,257,187)
Corporate administrative expenses (8,644,503) (8,852,615) (8,679,840)
Net loss on foreign exchange (1,529,309) 0 0
Finance costs (37,078) (30,594) (20,401)
Net Changes in fair value of convertible note liability (144,115) (125,317) (139,048)
Loss before income tax expense (61,434,165) (42,716,625) (39,896,348)
Income tax expense 0 0 0
Loss after income tax expense for the year (61,434,165) (42,716,625) (39,896,348)
Other Comprehensive Income/(Loss)      
Exchange differences on the translation of foreign operations 14,384,243 (1,421,191) 3,592,502
Other comprehensive income/(loss) for the year, net of tax 14,384,243 (1,421,191) 3,592,502
Total comprehensive loss for the year (47,049,922) (44,137,816) (36,303,846)
Loss for the year is attributable to:      
Owners of Immutep Limited (61,434,165) (42,716,625) (39,896,348)
Total comprehensive loss for the year is attributable to:      
Owners of Immutep Limited $ (47,049,922) $ (44,137,816) $ (36,303,846)
Basic loss per share $ (0.0422) $ (0.0356) $ (0.0447)
Diluted loss per share $ (0.0422) $ (0.0356) $ (0.0447)